Local and systemic expression of inducible nitric oxide synthase in comparison with that of cyclooxygenase-2 in rat carrageenin-induced pleurisy. 2005

Hideyuki Fujisawa, and Satoko Nakagawa, and Yura Ohkubo, and Miwako Matsui, and Sayuri Yamaguchi, and Michiko Kawamura, and Ko Hatanaka, and Yasuaki Kawakubo, and Yoshisuke Hiramoto, and Hirosuke Kobayashi, and Yoshiteru Harada
Department of Mediator and Signal Transduction Pharmacology, Kitasato University Graduate School of Medical Sciences, Japan.

Expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) is up-regulated in response to inflammatory stimuli. To evaluate the extent to which local pleural inflammation involves additional site in the pleural cavity and elsewhere, we investigated the time course of the levels of iNOS and its product in the inflammatory and other sites, and compared those with a level of COX-2 in rat carrageenin-induced pleurisy. The exudate and plasma NOx levels rose, reaching peaks at 9 and 14 h, respectively. Both COX-2 and iNOS became detectable in exudate leukocytes, their levels reaching peaks at 3 and 9 h after irritation, respectively. COX-2 was detectable mainly in neutrophils, but iNOS was detectable in both neutrophils and mononuclear leukocytes. Furthermore, iNOS became detectable in neutrophils and mononuclear leukocytes in enlarged parathymic lymph nodes from 3h in addition to those in peripheral blood and Kupffer cells from 3 to 14 h, respectively. The gene product is also detectable in thymic large dendritic cells of pleurisy-induced rats as well as normal control rats. COX-2 became detectable in stellar dendritic cells of the enlarged draining lymph nodes from 14 h. Thus, these gene products were induced in the immediate proximity of regional lymph nodes, and even at a considerable distance of liver by the local inflammatory stimulus. Although their expression pattern was quite different from each other, these gene products were detectable in phagocytic cells.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008297 Male Males
D009566 Nitrates Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical. Nitrate
D009573 Nitrites Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M Nitrite
D010998 Pleurisy INFLAMMATION of PLEURA, the lining of the LUNG. When PARIETAL PLEURA is involved, there is pleuritic CHEST PAIN. Pleuritis,Pleurisies,Pleuritides
D011451 Prostaglandin-Endoperoxide Synthases Enzyme complexes that catalyze the formation of PROSTAGLANDINS from the appropriate unsaturated FATTY ACIDS, molecular OXYGEN, and a reduced acceptor. Fatty Acid Cyclo-Oxygenase,PGH Synthase,Prostaglandin H Synthase,Prostaglandin Synthase,Prostaglandin-Endoperoxide Synthase,Arachidonic Acid Cyclooxygenase,Cyclo-Oxygenase,Cyclooxygenase,Cyclooxygenases,Hydroperoxide Cyclase,PGH2 Synthetase,Prostaglandin Cyclo-Oxygenase,Prostaglandin Cyclooxygenase,Prostaglandin Endoperoxide Synthetase,Prostaglandin G-H Synthase,Prostaglandin H2 Synthetase,Prostaglandin Synthetase,Cyclase, Hydroperoxide,Cyclo Oxygenase,Cyclo-Oxygenase, Fatty Acid,Cyclo-Oxygenase, Prostaglandin,Cyclooxygenase, Arachidonic Acid,Cyclooxygenase, Prostaglandin,Endoperoxide Synthetase, Prostaglandin,Fatty Acid Cyclo Oxygenase,G-H Synthase, Prostaglandin,Prostaglandin Cyclo Oxygenase,Prostaglandin Endoperoxide Synthases,Prostaglandin G H Synthase,Synthase, PGH,Synthase, Prostaglandin,Synthase, Prostaglandin G-H,Synthase, Prostaglandin H,Synthase, Prostaglandin-Endoperoxide,Synthases, Prostaglandin-Endoperoxide,Synthetase, PGH2,Synthetase, Prostaglandin,Synthetase, Prostaglandin Endoperoxide,Synthetase, Prostaglandin H2
D002351 Carrageenan A water-soluble extractive mixture of sulfated polysaccharides from RED ALGAE. Chief sources are the Irish moss CHONDRUS CRISPUS (Carrageen), and Gigartina stellata. It is used as a stabilizer, for suspending COCOA in chocolate manufacture, and to clarify BEVERAGES. Carrageenin,iota-Carrageenan,kappa-Carrageenan,lambda-Carrageenan,iota Carrageenan,kappa Carrageenan,lambda Carrageenan
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal

Related Publications

Hideyuki Fujisawa, and Satoko Nakagawa, and Yura Ohkubo, and Miwako Matsui, and Sayuri Yamaguchi, and Michiko Kawamura, and Ko Hatanaka, and Yasuaki Kawakubo, and Yoshisuke Hiramoto, and Hirosuke Kobayashi, and Yoshiteru Harada
December 1999, Naunyn-Schmiedeberg's archives of pharmacology,
Hideyuki Fujisawa, and Satoko Nakagawa, and Yura Ohkubo, and Miwako Matsui, and Sayuri Yamaguchi, and Michiko Kawamura, and Ko Hatanaka, and Yasuaki Kawakubo, and Yoshisuke Hiramoto, and Hirosuke Kobayashi, and Yoshiteru Harada
November 1994, British journal of pharmacology,
Hideyuki Fujisawa, and Satoko Nakagawa, and Yura Ohkubo, and Miwako Matsui, and Sayuri Yamaguchi, and Michiko Kawamura, and Ko Hatanaka, and Yasuaki Kawakubo, and Yoshisuke Hiramoto, and Hirosuke Kobayashi, and Yoshiteru Harada
August 2000, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
Hideyuki Fujisawa, and Satoko Nakagawa, and Yura Ohkubo, and Miwako Matsui, and Sayuri Yamaguchi, and Michiko Kawamura, and Ko Hatanaka, and Yasuaki Kawakubo, and Yoshisuke Hiramoto, and Hirosuke Kobayashi, and Yoshiteru Harada
July 2000, Carcinogenesis,
Hideyuki Fujisawa, and Satoko Nakagawa, and Yura Ohkubo, and Miwako Matsui, and Sayuri Yamaguchi, and Michiko Kawamura, and Ko Hatanaka, and Yasuaki Kawakubo, and Yoshisuke Hiramoto, and Hirosuke Kobayashi, and Yoshiteru Harada
January 1995, Advances in pharmacology (San Diego, Calif.),
Hideyuki Fujisawa, and Satoko Nakagawa, and Yura Ohkubo, and Miwako Matsui, and Sayuri Yamaguchi, and Michiko Kawamura, and Ko Hatanaka, and Yasuaki Kawakubo, and Yoshisuke Hiramoto, and Hirosuke Kobayashi, and Yoshiteru Harada
March 2013, Toxicology and industrial health,
Hideyuki Fujisawa, and Satoko Nakagawa, and Yura Ohkubo, and Miwako Matsui, and Sayuri Yamaguchi, and Michiko Kawamura, and Ko Hatanaka, and Yasuaki Kawakubo, and Yoshisuke Hiramoto, and Hirosuke Kobayashi, and Yoshiteru Harada
November 2014, European journal of pharmacology,
Hideyuki Fujisawa, and Satoko Nakagawa, and Yura Ohkubo, and Miwako Matsui, and Sayuri Yamaguchi, and Michiko Kawamura, and Ko Hatanaka, and Yasuaki Kawakubo, and Yoshisuke Hiramoto, and Hirosuke Kobayashi, and Yoshiteru Harada
April 2003, Zhongguo fei ai za zhi = Chinese journal of lung cancer,
Hideyuki Fujisawa, and Satoko Nakagawa, and Yura Ohkubo, and Miwako Matsui, and Sayuri Yamaguchi, and Michiko Kawamura, and Ko Hatanaka, and Yasuaki Kawakubo, and Yoshisuke Hiramoto, and Hirosuke Kobayashi, and Yoshiteru Harada
September 2001, American journal of physiology. Gastrointestinal and liver physiology,
Hideyuki Fujisawa, and Satoko Nakagawa, and Yura Ohkubo, and Miwako Matsui, and Sayuri Yamaguchi, and Michiko Kawamura, and Ko Hatanaka, and Yasuaki Kawakubo, and Yoshisuke Hiramoto, and Hirosuke Kobayashi, and Yoshiteru Harada
January 2004, Prostaglandins & other lipid mediators,
Copied contents to your clipboard!